PMID-sentid	Pub_year	Sent_text		comp_official_name	comp_offsetprotein_name	organism	prot_offset
33773404-0	2021	SMYD3 confers cisplatin chemoresistance of NSCLC cells in an ANKHD1-dependent manner.	Cisplatin	14-23	SET and MYND domain containing 3	Homo sapiens	0-5	
33773404-8	2021	RESULTS: Highly expressed SMYD3 was observed in NSCLC tissues or cells, acted as a sensitive indicator for NSCLC, correlated with higher TNM stages or resistant to DDP treatment, and shorter overall survival.	Cisplatin	164-167	SET and MYND domain containing 3	Homo sapiens	26-31